Sage Journals: Discover world-class research

Molecular Changes in the Nasal Cavity after N,N -dimethyl-p-toluidine Exposure

Abstract

Keywords

Introduction

Material and Method

Experimental Design

Methemoglobin Assay

Nasal Cavity Tissue Collection

Nasal Cavity LCM

Nasal Cavity RNA Extraction and Analysis

Microarray Analysis

Data Normalization

Statistical Assessment of Differential Gene Expression

Nanostring Analysis

Results

Survival and Body Weights

Nasal Tissue Histopathology

Nasal Tissue Dissection from Frozen Specimens

Nasal Tissue Significant Gene Transcripts in the Nasal Cavity Transitional Cell Epithelium

Discussion

Footnotes

References

Supplementary Material

Abstract

Keywords

Introduction

Material and Method

Experimental Design

Methemoglobin Assay

Nasal Cavity Tissue Collection

Nasal Cavity LCM

Nasal Cavity RNA Extraction and Analysis

Microarray Analysis

Data Normalization

Statistical Assessment of Differential Gene Expression

Nanostring Analysis

Results

Survival and Body Weights

Nasal Tissue Histopathology

Nasal Tissue Dissection from Frozen Specimens

Nasal Tissue Significant Gene Transcripts in the Nasal Cavity Transitional Cell Epithelium

Discussion

Footnotes

References

Supplementary Material

Acknowledgments

Author Contributions

Authors’ Note

Declaration of Conflicting Interests

Funding

Supplemental Material

Acknowledgments

Author Contributions

Authors’ Note

Declaration of Conflicting Interests

Funding

Supplemental Material

N, N-dimethyl-p-toluidine (DMPT; Cas No. 99-97-8), an accelerant for methyl methacrylate monomers in medical devices, is a nasal cavity carcinogen according to a 2-yr cancer study of male and female F344/N rats, with the nasal tumors arising from the transitional cell epithelium. In this study, we exposed male F344/N rats for 5 days to DMPT (0, 1, 6, 20, 60, or 120 mg/kg [oral gavage]) to explore the early changes in the nasal cavity after short-term exposure. Lesions occurred in the nasal cavity including hyperplasia of transitional cell epithelium (60 and 120 mg/kg). Nasal tissue was rapidly removed and preserved for subsequent laser capture microdissection and isolation of the transitional cell epithelium (0 and 120 mg/kg) for transcriptomic studies. DMPT transitional cell epithelium gene transcript patterns were characteristic of an antioxidative damage response (e.g., Akr7a3, Maff, and Mgst3), cell proliferation, and decrease in signals for apoptosis. The transcripts of amino acid transporters were upregulated (e.g., Slc7a11). The DMPT nasal transcript expression pattern was similar to that found in the rat nasal cavity after formaldehyde exposure, with over 1,000 transcripts in common. Molecular changes in the nasal cavity after DMPT exposure suggest that oxidative damage is a mechanism of the DMPT toxic and/or carcinogenic effects.

nasal cavity toxicity molecular markers

N, N-dimethyl-p-toluidine (DMPT; Figure 1) is a high production chemical used as an accelerant in methyl methacrylate monomers in medical devices. DMPT exposure is of concern because it can leach out from medical devices and dental materials (L. Wang et al. 2013). DMPT has other commercial uses and is listed in over 900 patents with the U.S. Patent Office (U.S. Patent and Trademark Office 2015). According to a 2-yr cancer study (National Toxicology Program [NTP] 2012), oral exposure to DMPT, a nongenotoxic chemical, produced liver cancer in rats (at 60 mg/kg) and mice (at 20 and 60 mg/kg) and nasal cavity cancer in rats (at 60 mg/kg). The State of California has listed DMPT as a chemical known to cause cancer (Office of Environmental Health Hazard Assessment 2014) based on the results of the DMPT rodent cancer study (NTP 2012).

Figure 1.

N, N-dimethyl-p-toluidine structure.

After oral administration, DMPT is rapidly absorbed in the rat and is excreted in the urine (Dix, Ghanbari, and Hedtke-Weber 2007). The major DMPT metabolite in the urine is p-(N-acetylhydroxyamino) hippuric acid. Two lesser metabolites are DMPT N-oxide and N-methyl-p-toluidine (Kim et al. 2007). After oral administration, DMPT is carcinogenic in the nasal cavity and liver of the rat. The DMPT toxicity and carcinogenic response in the nasal cavity occurred in the transitional epithelium (NTP 2012). The transitional cell epithelium is composed of 2 cell layers of nonciliated cuboidal or columnar surface cells and basal cells with a scarcity of mucous secretory cells (Hardisty et al. 1999; Harkema, Carey, and Wagner 2006). It is found on the lateral walls of the nasal cavity and on turbinate tips. In a series of NTP cancer studies, other chemicals were also found to cause nasal tumors. Often the origin of the nasal cavity tumors in rats is not specified or apparent. Compounds investigated by NTP that cause nasal cavity epithelial tumors include cumene (TR 542; inhalation study), 1,2-dibromo-3-chloropropane (TR 206; inhalation study), 1,2-dibromoethane (TR 210; inhalation study), 2,3-dibromo-1-propanol (TR 400; dermal study), dimethylvinyl chloride (TR 306; oral gavage study), 1,4-dioxane (TR 80; drinking water study), 1,2-epoxybutane (TR 306; inhalation study), naphthalene (TR 410; inhalation study), 2,6-xylidine (TR 278; feed study), and propargyl alcohol (TR 552; inhalation study; NTP 2014).

The current work describes molecular changes in the rat nasal cavity transitional epithelium after 5 days of DMPT oral exposure. Rapid dissection was used to capture and preserve a sample of nasal tissue for subsequent laser capture microdissection (LCM) to obtain transitional cell epithelium tissue for RNA extraction and toxicogenomic evaluation. Methemoglobin was added as an end point because DMPT has previously been shown to cause methemoglobinemia in rodents (NTP 2012). This article expands our knowledge on the use of transcriptomic findings to identify early changes in the nasal cavity that can elucidate mechanisms or identify early disease biomarkers. While this study focuses on early exposure transcriptomic patterns, other human exposure scenarios may involve longer-term exposure to DMPT. The objective of this study was to evaluate if early molecular changes in the nasal cavity transitional cell epithelium in rats after a 5-day DMPT oral exposure would help to elucidate pathways and mechanisms leading to toxicity.

DMPT (lot #C15Y012, >99% pure; Alfa Aesar, Ward Hill, MA) was prepared for oral gavage administration in corn oil (Lot# 12-542; Welch, Holme & Clark Co., Inc. Newark, NJ) to deliver DMPT at doses of 0, 1, 6, 20, 60, or 120 mg/kg/day for 5 consecutive days to male F344/N rats in a volume of 2.5-ml/kg body weight. The high dose of 120 mg/kg was selected as a 5-day maximum tolerated dose based on the findings from a 13-week DMPT study, in which the body weights of male F344/N rats at the end of a 125 mg/kg exposure were 12% lower than body weights of controls (NTP 2012). The lower doses (1–60 mg/kg) were selected to give a response over a broad dose range. Male F344/N rats (5 animals/dose level) were obtained from Taconic Laboratory, Germantown, NY. Five male rats were added to the high-dose and control groups for frozen nasal tissue collection and RNA extraction. At the start of the study, the animals were 5–6 weeks of age. The animals were housed 2 per cage. Tap water and NTP-2000 diet (Zeigler Brothers, Inc. Gardners, PA) were made available ad libitum.

The care of animals on this study was according to National Institutes of Health (NIH) procedures as described in the “The U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals,” available from the Office of Laboratory Animal Welfare, NIH, Department of Health and Human Services, RKLI, Bethesda, MD or online at http://grants.nih.gov/grants/olaw/olaw.htm#pol. The protocol was approved by the laboratory where the animals were housed and dosed (Alion Science and Technology Animal Care and Use Committee).

Blood was collected from the retroorbital plexus for methemoglobin determination from the core rats according to the methods of Evelyn and Malloy (1938). Disodium hydrogen phosphate, potassium dihydrogen phosphate, acetic acid, aqueous sodium cyanide, and aqueous potassium ferricyanide were purchased from Sigma Chemical Company, St. Louis, MO.

Animals were euthanized 24 hr after the last dose under CO₂ gas. After decapitation, the skin, mandible, and nasal vestibule were removed from the head. Animals not designated for LCM were infused with 10% neutral-buffered formalin through the nasopharyngeal groove and immersed in the fixative for 72 hr. Following fixation, the heads were decalcified in a 3:1 Formical 2000™ (Decal Chemical Corporation, Tallman, NY)/1× phosphate-buffered saline (HyClone™ Laboratories Inc., Logan, UT) solution for 60 hr. Following a rinse in water, the nasal cavities were trimmed to obtain representative sections of levels 1, 2, and 3. For level 1, a cut was made directly behind the upper incisor teeth as described in traditional rat nasal cavity trimming (Boorman, Morgan, and Uriah 1990). Level-2 trimming was modified from the traditional protocol. Instead of cutting directly behind the incisive papilla, the cut was made between the incisive papilla and the first palatal ridge. For level 3, the tissue trimming was modified to section directly in front of the first molar and not the traditional method of sectioning through the second molar. These modifications were made to obtain improved sections of the respiratory and ethmoid turbinates, respectively. Representative sections of the nasal cavity at levels 1, 2, and 3 were routinely processed and paraffin embedded.

For the additional control and high-dose group animals designated for frozen nasal cavity tissue, transitional epithelium from level 1 was collected by LCM and RNA extracted. Nasal cavity tissue was collected within 5 min to preserve RNA integrity. For LCM studies, the skin, mandible, and nasal vestibule were removed from the head. A cut along the sagittal suture at the anterior and posterior ends initiated the splitting of the calvarium. Placing the head on the dorsal surface, a disposable razor blade was placed between the incisors, along the palatine suture of the hard and soft palate. A cut through the hard and soft palate divided the head into 2 sagittal sections. Each half of the head was placed with the cut surface up in a self-made styrofoam mold. Naso- and maxilloturbinates were removed, and the epithelium along with submucosal tissue stripped from the inner wall of the calvarium at levels 1 and 2 of the nasal cavity. Tissue strips were placed in a cryomold on dry ice, filled with optimal cutting temperature compound (OCT; Sakura Finetek U.S.A., Inc., Torrance, CA) and stored at −80°C. Tissue strips were collected and frozen within 5 min after euthanasia.

The nasal cavity membrane strips were sectioned at 8 μm on the cryostat, with hematoxylin and eosin (H&E) stains performed on every fifth section. Unstained sections were placed on polyethylene terephthalate foil slides (ACSS, Lenior, TN) for LCM. The H&E-stained MAP sections were examined microscopically, and the transitional epithelium identified and marked on the coverslip as a guide for the laser microdissection. Laser microdissection of the transitional epithelium was done on cresyl violet-stained sections.

The presence of transitional epithelium varied from one section to the next, with the epithelium often absent from early sections and sometimes depleted from the deeper sections of the frozen block. Transitional epithelium was identified by the cuboidal nature of the epithelium, as opposed to the taller, columnar appearance of the respiratory epithelium. Other features used for identification of transitional epithelium included no or rare ciliated cells and goblet cells and the usual appearance of 2 cell layers (basal cell and cuboidal cell). Only transitional epithelium on the outer surface of the stripped membranes was labeled and microdissected to facilitate both the labeling and the microdissection process. Transitional epithelium from approximately 40 sections per sample was pooled for the microarray analysis. The amount of RNA obtained for each nasal cavity was 5.7–12.6 ng.

After LCM of the nasal cavity transitional cell epithelium, RNA was extracted from the control and 120 mg/kg groups, according to the NTP protocol for laser capture microdissected samples (http://www.niehs.nih.gov/research/resources/protocols/extraction/picoscale/index.cfm). The RNA was analyzed for quantity and purity by ultraviolet analysis using the NanoDrop ND-1000 (NanoDropTechnologies, Wilmington, DE). Samples were concentrated using Microcon filters (Millipore, Billerica, MA). All samples were evaluated for RNA integrity by gel electrophoresis using the Flash Gel RNA cassette system (Lonza, Rockland, ME).

Gene expression analysis was conducted using Affymetrix Rat Genome 230 2.0 GeneChip^® arrays (Affymetrix, Santa Clara, CA). Four nanograms (4 ng) of total RNA was amplified as directed in the WT-Ovation Pico RNA Amplification System protocol and labeled with biotin following the Encore Biotin Module. Five micrograms (5 μg) of amplified, biotin-labeled RNAs were fragmented and hybridized to each array for 18 hr at 45°C in a rotating hybridization. Array slides were stained with streptavidin/phycoerythrin utilizing a double-antibody staining procedure and then washed for antibody amplification according to the GeneChip^® Hybridization, Wash and Stain Kit, and user manual following protocol FS450-0004. Arrays were scanned in an Affymetrix Scanner 3000.

Probe intensity data from all Rat Genome 230 version 2 Affymetrix GeneChip^® arrays were read into the R software environment (http://www.R-project.org) directly from .CEL files using the R/affy package (Gautier et al. 2004). Probe-level data quality was assessed using image reconstruction, histograms of raw signal intensities, and hierarchical clustering of samples. Normalization was carried out using the robust multiarray average (RMA) method using all probe intensity data sets together (Irizarry et al. 2003). The RMA method adjusts the background intensities of perfect match probes, applies a quantile normalization, and calculates final expression measures using the Tukey median polish algorithm. RMA scatter plots were used as an additional quality control measure.

Gene expression between control and treated nasal cavities was made for each probe set using a bootstrap t-test approach. Pairwise tests were conducted while controlling the false discovery rate (FDR) at the 5% level. All statistical calculations were performed in the ORIOGEN, version 4.01, software package using 10,000 bootstrap samples (Peddada et al. 2005).

Data were analyzed using the ingenuity pathway analysis database of biologic networks (www.ingenuity.com) and Nextbio (www.nexbio.com), a web-based tool that can be used to compare an experimental gene expression signature to thousands of genomic signatures derived from published microarray data sets in public databases (Kupershmidt et al. 2010). This data mining approach is based on rank-based statistical procedures and is analogous to the gene set enrichment method (Subramanian et al. 2005). NextBio uses a Running Fisher algorithm that can accommodate information from both the query and target sequences and can incorporate data of different sizes and filter thresholds in order to find the most significant signal in a ranked gene expression signature. The resulting correlation scores describe the association between a given gene set and an extensive set of publicly available studies (Kupershmidt et al. 2010).

The upstream regulator analysis presented here is based on known relationships between transcriptional factor molecules and targets stored in the ingenuity knowledge base. For each transcription factor, an overlap p value is used to compare the overlap between the number of known transcription factor targets and the number of targets found in the DMPT gene list.

Nanostring nCounter is a hybridization-based platform for multiplexing gene expression from total RNA (NanoString^©; Seattle, WA; www.nanostring.com). Non-cross-reactive probes are custom synthesized and mixed for validation transcripts and normalization (e.g., housekeeping) transcripts. Microarray results were confirmed for nasal epithelium RNA samples using the nCounter platform by utilizing a Custom CodeSet consisting of 12 DMPT transcripts found to be significantly altered from control after microarray analysis that included Sprr1a, Slc7a11, Akr7a3, Cyp3a13, Maff, Psca, Krt4, Ngfr, Nrgn, Ermn, Ccno, and GP2. Seven housekeeping genes (Gapdh, Hprt1, LOC100365008, Med15, Rpl7, Spire1, and ZNF91 L) and a gene that was not significantly increased with DMPT (Agm) were used for normalization. For nasal cavity RNA samples in Nanostring analysis, 100 ng of amplified complementary DNA were obtained utilizing the Nugen™ Ovation Pico WTA System (v2; Nugen Technologies, Inc., San Carlos, CA). Gene expression was quantified on the nCounter Digital Analyzer™, and raw and normalized counts were generated with nSolver (version 2.5)™ software. All data passed nSolver’s quality analysis/quality control. Data were normalized utilizing the manufacturer’s positive and negative control probes as well as the housekeeping genes. Subsequently, the data were imported into Partek™ Genomic Suite (6.6), quantile normalized, and further inspected for separation of control and DMPT groups.

There was no effect on survival at any DMPT exposure level in this study (all animals lived until the end of the 5-day exposure). Mean body weights for the 1, 6, 20, 60, and 120 mg/kg exposure groups were 104%, 103%, 92%, 94%, and 90% of control mean body weight at the end of the 5-day exposure. Methemoglobin levels were not increased in treated rats (data not shown).

Hyperplasia of the nasal cavity transitional epithelium was observed in the 60 and 120 mg/kg dose groups (Table 1 and Figure 2A and B). Hyperplasia of the transitional epithelium was characterized by an increase in cell layers and an increase in the disorganization of the cells. Control transitional epithelium was typically 1–2 cell layers thick, whereas hyperplastic epithelium was 3 or more layers thick and the cells appeared jumbled and disorganized, with irregular piling. Only minimal to mild severity hyperplasia of the transitional epithelium was recorded; minimal lesions tended to involve less area than mild lesions. Typically, mild lesions would involve the tips of the nasoturbinates and most of the lateral wall, while minimal lesions might be restricted to the tips of the nasoturbinates, or involve the tips of the nasoturbinates and just a small focal area of the lateral wall. Also, mild lesions tended to be thicker, typically 4 cell layers, whereas the minimal lesions were usually only 3 cell layers thick. None of the lesions had more than 4 or 5 cell layers. The disorganization of the hyperplastic transitional epithelium made determining the exact number of cell layers difficult. The hyperplastic epithelium also contained clear vacuoles within some cells, and occasionally there was a shrunken, eosinophilic cell present within the epithelial layer.

Table 1.

Nasal Cavity Lesions in Male Rats after 5 Days of DMPT Exposure.

Note: Five animals per group. DMPT = N, N-dimethyl-p-toluidine.

^aSeverity of lesion.

Figure 2.

(A) Lateral wall region of nasal level I from a young, male F344/N rat exposed to vehicle control corn oil by gavage for 5 days. The transitional epithelium is 1–2 cell layers thick and fairly well organized (arrows). Hematoxylin and eosin stain. (B) Lateral wall region of nasal level I from a young, male F344/N rat exposed to 120 mg/kg N, N-dimethyl-p-toluidine by gavage for 5 days. The transitional epithelium is characterized by a thickened, disorganized epithelium (arrows), with occasional vacuoles (arrowheads). Hematoxylin and eosin stain.

In nasal level 3, olfactory epithelial necrosis was characterized by a layer of proteinaceous substance and cell debris overlying a thin, disorganized layer of olfactory epithelium (Figure 3A–E). The remaining olfactory epithelium was hypocellular, disorganized, vacuolated, and contained individual dead cells, which were characterized by shrunken, eosinophilic round bodies. There were focal areas of attenuated epithelium in affected locations, indicative of epithelial cell loss. The dorsal meatus and immediately adjacent areas were most commonly and severely affected. Severity of olfactory epithelium necrosis was based upon the extent of the lesion as well as the amount of changes seen in the affected area. Minimal lesions consisted of small areas of dorsal meatus olfactory epithelium characterized by a slight disorganization and vacuolation of the epithelium, which contained decreased numbers of cells within the epithelium. There was a thin layer of proteinaceous and cell debris overlying affected areas. Mild lesions involved a larger area of the dorsal meatus, and the epithelium contained obviously fewer cells. Moderate necrosis involved most of the dorsal meatus and immediately adjacent areas. There was a thick layer of debris overlying the epithelium, which was moderately attenuated in areas. The remaining epithelium was disorganized and vacuolated. The one occurrence of mild olfactory degeneration that was recorded differed from necrosis in that the epithelium appeared normal in thickness and better organized than that in the animals with necrosis. The epithelium contained numerous vacuoles but lacked evidence of cell death and overlying debris (Figure 3F). One animal exposed to 20 mg/kg DMPT had mild dilation of the vessels in the lamina propria in nasal level 3; this was recorded as angiectasis. Angiectasis was not seen in any other animals in this study.

Figure 3.

(A). Normal olfactory epithelium in the dorsal meatus region of nasal level 3 from a young, male F344/N rat exposed to vehicle control corn oil by gavage for 5 days. The olfactory epithelium is organized and uniform in height (arrows). Hematoxylin and eosin stain H&E. (B). Higher magnification of Figure 3A. The cells are densely packed and uniform in size, and the epithelium is uniform in height. H&E (25×). (C). Dorsal meatus region of nasal level 3 from a young, male F344/N rat exposed to120 mg/kg N, N-dimethyl-p-toluidine (DMPT) by gavage for 5 days. Olfactory epithelial necrosis, characterized by irregularity and decreased cellularity of the olfactory epithelium, is present (arrows). There is cellular debris on the surface of the epithelium (arrowheads) and in the lumen of the nasal cavity. H&E. (D). Olfactory epithelial necrosis in the dorsal meatus region of nasal level 3 in a young, male F344/N rat exposed to120 mg/kg DMPT by gavage for 5 days. The olfactory epithelium is decreased in cellularity, vacuolated (arrows) and irregular. H&E. (E). Dorsal meatus region of nasal level 3 from a young, male F344/N rat Figure 3. (continued) exposed to120 mg/kg DMPT by gavage for 5 days. There is a thick layer of necrotic debris overlying the olfactory epithelium (arrows). The cells of the epithelium are disorganized and many are vacuolated (arrowheads). H&E. (F). Olfactory epithelial degeneration in the dorsal meatus region of nasal level 3 in a young, male F344/N rat exposed to 120 mg/kg DMPT by gavage for 5 days. The olfactory epithelium is vacuolated (arrows) but appears close to normal in height. H&E.

Each of the 10 nasal specimens (5 control and 5 DMPT treated 120 mg/kg specimens) contained both transitional and respiratory epithelium, which varied from one section to the next (Figure 4A and B). However, enough transitional epithelium was laser microdissected in each of the 10 specimens to allow for sufficient RNA to be extracted from the harvested material. For each specimen, the frozen sections were examined blindly, and the epithelium could be correctly identified as either control or treated on the basis of changes seen in the transitional epithelium. These changes in the transitional epithelium of the treated animals included karyomegaly, crowding of nuclei, loss of basal polarity of the nuclei, and sometimes 3 layers of cells indicative of mild hyperplasia.

Figure 4.

(A). Frozen nasal section from control rat showing transitional cell epithelium. (B). Frozen nasal section from treated rat showing transitional cell epithelium, which is thickened by an increase in number and size of the cells.

Principal component analysis across the control and 120 mg/kg samples separated the samples into control and treated groups (Figure 5). Moreover, global gene expression patterns showed a clear difference between treated and control samples. Using a FDR threshold of 0.05, there were 2,561 differentially expressed transcripts (corresponding to 1,730 genes) in the 120 mg/kg group (vs. control). Nanostring analysis of selected transcripts confirmed the direction of the DMPT-induced transcript change (upregulated: Sprr1a, Slc7a11, Akr7a3, Maff, Cyp3a13, Psca, Krt4, and Ngfr; or downregulated: Nrgn, Ermn, Ccno, and GP2; Figure 6).

Figure 5.

Principal component analysis. The first 3 principal components comparing global gene expression profiles of rats exposed to vehicle control and N, N-dimethyl-p-toluidine treatment in the nasal cavity. Samples cluster within group (vehicle or treated), indicating that there are differences in expression between the 2 treatment conditions.

Figure 6.

Nanostring and microarray platform comparison of gene transcript fold change. Bars represent n = 10 rats/group.

Using Ingenuity Pathway Analysis the differentially expressed transcripts mapped to 1,730 genes, with a total of 994 upregulated genes and 736 downregulated genes (Supplement 1). There were 32 transcripts upregulated > 10-fold, and 38 transcripts downregulated more than 5-fold (Table 2; Supplement 1). Genes predicted to be upstream regulators of the DMPT molecular response were Myc (↑2.1, MYCT1; Fu et al. 2011), E2F (↑1.7, E2F1; ↑2.0, E2F8), and Rb pathways (Table 3; Ma et al. 2013).

Table 2.

DMPT Induction of Significant Transcripts in the Nasal Cavity Transitional Cell Epithelium.

Transcript^a	Description	Background
Antioxidant response and NrF2 pathway
AKr7A3 (↑14.8)^b	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) (detoxification gene)	May contribute to the protection against AFB1-induced hepatotoxicity (Knight et al. 1999); cellular defense against the toxic/mitogenic effects of the dialdehyde metabolite of AFB1 (Merrick et al. 2012)
SLc7A11 (↑17)	Solute carrier family 7	Increase in transporter caused by oxidative-stress inducing paraquat (Kobayashi et al. 2012); antioxidant response (Singer et al. 2015)
SRXN1 (↑7.5)	Sulfiredoxin 1	Protein critical for redox balance (Baek et al. 2012)
MGST3 (↑4.0)	Microsomal glutathione S-transferase 3	Utilize reduced glutathione for the cellular defense against oxygen-free radicals (Thameem et al. 2003)
TXNRD1 (↑3.2)	Thioredoxin reductase 1	Helps mediate oxidative stress (Das et al. 2011)
NQO1 (↑1.7)	NAD(P)H dehydrogenase, quinone 1	Encodes a cytoplasmic 2-electron reductase
Prdx4 (↑1.6)	Peroxiredoxin 4	Codes for an antioxidant defense protein (Basu et al. 2011)
G6PD (↑1.4)	Glucose-6-phosphate dehydrogenase	Produce NADPH, a key electron donor in the defense against oxidizing agents (Pandolfi et al. 1995)
Cell proliferation and cancer
SCIN (↑14.6)	SCINDERIN	Expressed by tumor cells rendering them resistant to cytotoxic T lymphocyte-mediated lysis (Hasmim et al. 2013)
MAFF (↑11.4)	V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F	MAFF in proinflammatory cytokine-mediated control of myometrial gene expression and provide the first link between a small MAF transcription factor and the inflammatory response (Massrieh et al. 2006)
KRT4 (↑8.5)	Keratin 4	Epithelial structural protein (Presland and Dale 2000)
Fabp5 (↑7.1)	Fatty acid protein	Promotes differentiation and cell proliferation (Dallaglio et al. 2013; Fang et al. 2010)
Cyp3a13 (↑11.4)	Cytochrome P450, family 3, subfamily a, polypeptide 13	CYP3a13 promoter shows putative binding sites for retinoid X receptor, pregnane X receptor, and estrogen receptor (Anakk et al. 2003); PPAR alpha pathway (Sahasrabuddhe et al. 2014)
PSCA (↑8.7)	Prostate stem cell antigen	Originally identified as a tumor antigen in prostate cancer but is found in other cancers (Yang et al. 2014) and in brain (Jensen et al. 2015); may regulate immune response, cell proliferation, and calcium flows (Yang et al. 2014; Jensen et al. 2015)
IGFBP6 (↑4.8)	Insulin-like growth factor binding protein 6	Promotes cell survival and inhibits apoptosis (Xu et al. 2009)
NGFR (↑3.887)	Nerve growth factor receptor	Nerve growth factors important in stem cell development (Cattaneo and McKay 1990)
RHOV (↑3.1)	Ras homolog family member V	Found to be overexpressed in lung cancers (Shepelev and Korobko 2013)
CASC5 (also n known as KNL1) (↑2.5)	Cancer susceptibility candidate 5	Kineticore protein required for spindle assembly checkpoint (Izawa and Pines 2015)
Sprr1 (↑28)	Small proline-rich protein 1A	Found in chronic atopic dermatitis skin lesions (Jarzab et al. 2010); functions as cornified envelope precursors (Fujimoto et al. 1997); upregulated early after tobacco smoke-induced squamous metaplasia (Tesfaigzi et al. 1996)
FHIT (↓2.1)	Fragile histidine triad	↓Liver after aflatoxin exposure (Merrick et al. 2012); considered a tumor suppressor gene (Waters et al. 2014)
Control of apoptosis
ACAA2 (↑2.387)	Acetyl-CoA acyltransferase 2	Attenuates apopotosis by binding to BNIP3 (Cao et al. 2008)
GP2 (↓8.8)	GP2 glycoprotein 2	Membrane protein secreted from intracellular zymogen granules; an autoantigen that triggers autoimmune reaction in Crohn’s disease (Pavlidis et al. 2012).
CCNO (UNG2) (↓7.2)	Cyclin	Novel cycle involved in forming complexes with CdK2 in apoptosis (Roig et al. 2009)
ERMN (↓6.7)	Ermin	Novel marker of myelinating oligodendroglia; plays a role in cytoskeletal rearrangements during the late wrapping and/or compaction phases of myelinogenesis (Brockschnieder et al 2006)
NRGN (↓5.3)	Neurogranin (protein kinase C substrate, RC3)	Human homolog of the neuron-specific rat RC3/neurogranin gene; gene encodes a postsynaptic protein kinase substrate that binds calmodulin in the absence of calcium (Zhong et al. 2009)
ACE (↓3.2)	Angiotensin I converting enzyme	Gene encodes an enzyme involved in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin

Note: NAD(P)H = nicotinamide adenine dinucleotide phosphate. DMPT = N, N-dimethyl-p-toluidine.

^aRed is an upregulated transcript; blue is a downregulated transcript.

^bFold change: DMPT versus control.

Table 3.

Transcription Regulators (|z| > 3).

Gene	Activation z Score	p Value of Overlap	Known Roles
NFE2L2	6.007	7.54E-16	Response to oxidative stress
E2F1	5.696	8.30E-20	Cell cycle; DNA replication
MYC	5.575	3.14E-21	Growth related
TBX2	4.536	1.35E-14	Mesoderm differentiation
FOXO1	4.417	1.14E-06	Insulin signaling; metabolic homeostasis in response to oxidative stress
SREBF1	4.148	1.93E-07	Lipid homeostasis
CCND1	3.891	7.13E-17	Cell cycle
FOXM1	3.814	8.07E-11	Cell cycle; DNA replication; mitosis
SREBF2	3.691	7.76E-14	Lipid homeostasis
E2F2	3.576	3.72E-12	Cell cycle; DNA replication
E2F3	3.400	8.88E-15	Cell cycle; DNA replication
HIF1A	3.311	1.32E-07	Response to hypoxia
MYCN	3.152	1.44E-03	Transcription factor function
RBL1	−3.345	2.12E-06	Cell division; tumor suppressor
RB1	−3.533	1.47E-15	Cell division; tumor suppressor
TCF3	−3.914	2.10E-10	Initiation of neuronal differentiation
CDKN2A	−4.960	2.77E-12	Negative regulator of proliferation

Note: Upstream regulators, ingenuity pathway analysis (www.ingenuity.com). UniProt knowledge base (www.uniprot.org).

DMPT exposure caused upregulation of 35/180 transcripts (e.g., Akr7a3, Maff, and Mgft3) in the NrF2 pathway (Supplement 2), a primary regulator of antioxidant response (Franco et al. 2014; Johnson et al. 2008). Expression of other antioxidant response genes was also increased (e.g., Srxn1, G6pd, and Prdx4; Bensellam et al. 2015).

Transcripts characteristic of epithelial-derived cancers (e.g., Slc7A11, Maff, Igfb3, and Igfb6) were upregulated more than 1.5-fold (Supplement 3). Cell proliferation signals were also upregulated (Supplement 4). DMPT gene transcript changes were predicted to alter cell death, necrosis, and/or apoptosis processes (e.g., ↓Gp2 and Ccno; Supplement 5).

In addition to upregulation of the protein transporter Slc7a11 (↑17.4), other membrane transporters were upregulated including Slc14a1 (↑4.6), Slc4a7 (↑3.2), Slc4A4 (↑3.0), Slc6a9 (↑2.9), Slcba1 (↑2.6), and Slc1a5 (↑2.5; Supplement 1).

NextBio software (accessed May 15, 2015) was used to compare the DMPT transcript changes with thousands of other microarray data sets accessed by algorithm. NextBio analysis showed the transcriptional changes induced by DMPT were most similar to those in the nasal cavity of adult male F344CrlBR rat following formaldehyde exposure (Supplement 6; Andersen et al. 2010). There were over 1,000 shared transcripts that were significantly changed by both DMPT and formaldehyde exposure. This included upregulation of Sprr1a, SLC7a11, Akr7a3, Scin, Maff, Psca, and Cyp3a9 and downregulation of Fhit, Nrgn, and Ace. The DMPT nasal cavity used for this transcriptomic analysis was transitional epithelium, while the nasal sample in the formaldehyde transcriptomic analysis contained transitional cell epithelium and other portions of the nasal cavity (e.g., respiratory epithelium; Andersen et al. 2010).

After a 5-day DMPT exposure, nasal cavity lesions developed in male F344/N rats, including hyperplasia of the transitional epithelium and degeneration/necrosis of the olfactory epithelium (at 60 and 120 mg/kg). Nasal lesions observed in this 5-day study occurred at the same target site of nasal cancer (transitional cell epithelium) as found in the 2-yr DMPT rat study (NTP 2012). In previous studies, after 13 weeks of DMPT exposure, there was treatment-related methemoglobinemia formation (NTP 2012), which occurs by oxidation of the heme moiety (Pallais, Mackool, and Pitman 2011). Data from the current study support a hypothesis that DMPT nasal toxicity and carcinogenicity effects are the result of oxidative damage (Dunnick et al. 2014; El-Gebali et al. 2013; NTP 2012).

The nasal cavity contains a low level of antioxidant-associated mucosubstances (Harkema, Carey, and Wagner 2006), making it susceptible to DMPT-induced oxidative damage. While 5 days of DMPT exposure were not sufficient for methemoglobin formation, it was sufficient for induction of nasal cavity transitional epithelium toxicity and gene transcript changes. This included activation of an Nrf2 antioxidant response, a process that protects from oxidative stress-induced cell death (Johnson et al. 2008) and provides antioxidant defense and maintenance of cellular redox potential (Franco et al. 2014). Upregulation of transcripts in the Nrf2 pathway included Mgst3 (microsomal glutathione S-transferase 3), G6pd (glucose-6-phosphate dehydrogenase), and Txnrd1 (thioreductase), whose protein products can function to reduce oxidative stress (Johnson et al. 2008). In addition, Nq01 (nicotinamide adenine dinucleotide phosphate dehydrogenase, quinone 1), a major cellular detoxification transcript, was upregulated (Nguyen, Nioi, and Pickett 2009).

Other transcripts induced by DMPT were Slc7a11 and Akr7a3 (Katsuoka et al. 2005). Slc7a11 protein regulates cysteine–glutamate exchange and maintenance of glutathione levels (Y. Huang et al. 2005). Akr7a3 expression occurs in the liver after aflatoxin treatment of rats and is a common defense mechanism after free radical generation in several tissue types (Merrick et al. 2012, 2013).

DMPT-induced transcripts included those associated with promoting and sustaining cell proliferation. This included increased expression of transcripts for Maff (a fibrosarcoma oncogene), Ras-related oncogene (Rhov), Psca (prostate oncogene), Casc (cancer susceptibility candidate 3), and Krt4 (an epithelial structural protein). Other transcripts upregulated are involved in xenobiotic metabolism (Cyp3a13; Anakk et al. 2003; Liu et al. 2013) or fatty acid transport (Fabp5; Fang et al. 2010). After long-term exposure, the upregulation of Ngfr (nerve growth factor receptor) may also enable cell proliferation (Jobling et al. 2015). Upstream regulators of the DMPT-induced nasal transcripts were predicted (based on Ingenuity Pathway Analysis) to be involved in carcinogenesis (e.g., MYC; Ng et al. 2011).

DMPT increased solute carrier transcripts that code for membrane transporters of various cell nutrients (El-Gebali et al. 2013; Hediger et al. 2013). An increase in the ability to transport nutrients into the cell can provide energy and building blocks for cell proliferation (Bhutia et al. 2015). Blocking membrane transporters has been proposed as a potential target for cancer therapy (El-Gebali et al. 2013).

DMPT transcript changes created a pattern consistent with changes that could eventually lead to a decrease in cell death and apoptosis including upregulation of (1) Scin, a transcript coding for the scinderin protein, which renders cells resistant to cytotoxic T-lymphocyte-associated lysis (Hasmim et al. 2013), (2) Srxn1 (sulfiredoxin), which codes for an enzyme that catalyzes the reduction of free radicals and prevents apoptosis (Baek et al. 2012), (3) Igfbp6 whose protein promotes cell survival and inhibits apoptosis (Xu et al. 2009), and (4) Acaa whose protein promotes attenuation of the activity of BNIP3, a proapoptotic protein (Cao et al. 2008).

DMPT-induced transcript changes suggest that events leading to apoptosis could eventually be suppressed. This included decreased expression of transcripts for (1) Ccno (cyclin) involved in apoptosis induction (Roig et al. 2009), (2) Gp2 (glycoprotein 2) coding for a structural protein reported to decrease cell proliferation (Werner et al. 2012), (3) Fhit (fragile histidine triad gene transcript) whose protein promotes apoptosis and suppresses cell proliferation (Q. Huang et al. 2014), and (4) Ace (angiotensin converting enzyme transcript), an enzyme which converts angiotensin I to the physiologic active peptide angiotensin II, a proapoptotic protein (X. Wang et al. 2015; Yi et al. 2014). Two other transcripts downregulated were Ermn, whose protein is an oligodendrocyte-specific protein surrounding myelin axons necessary for action potentials (Brockschnieder et al. 2006), and Nrgn involved in promoting synaptic transmission (Zhong et al. 2009).

Some of the DMPT-induced transcripts have multiple functions. For example, Nrgn (Parsi et al. 2012) and BcL2L11 (Kuan et al. 2000; Petrocca, Vecchione, and Croce 2008) have both a proapoptotic function and a tumor suppressor function (Parsi et al. 2012).

The DMPT transcript patterns were similar to those in the rat nasal cavity after formaldehyde exposure (Andersen et al. 2010), a nasal cavity carcinogen in both rats and humans (International Agency for Research on Cancer 2012). DMPT and formaldehyde both induced transcripts characteristic of an antioxidant response (e.g., Akr7a3 and Srxn1), transcripts in cancer (e.g., Maff and Psca), and transcripts in cell proliferation and differentiation (e.g., Sprr1a). PSCA is usually associated with prostate cancer (Yang et al. 2014) but now appears to also be an important transcript in the nasal cavity. Sprr1a (small proline-rich protein 1a) is considered to be an early biomarker of epithelial cell differentiation and is also upregulated after tobacco smoke exposure (Tesfaigzi et al. 1996). Downregulation of Fhit was seen with both formaldehyde and DMPT and also reported to be downregulated after other carcinogen exposures (Merrick et al. 2012). Additional transcriptomic studies with other nasal carcinogens would add to our knowledge on the use of early molecular makers for identifying toxic and carcinogenic processes in the nasal cavity (e.g., ↑Akr7a3, Srxn, Maff; Psca; and ↓Fhit). Development of such biomarkers would help facilitate the use of fewer animals and shorter-term studies for hazard identification.

DMPT transcript changes included upregulation of antioxidative stress pathways. Other studies show that oxidative stress can eventually lead to DNA damage (Klaunig et al. 2011) and promote disease pathways. This is a possible mechanism for DMPT-induced disease (Figure 7). DMPT nasal cavity molecular changes were characteristic of events leading to increased cell proliferation and decreased apoptosis often considered to be hallmarks of cancer (Hanahan and Weinberg 2011). Molecular changes in the nasal cavity after DMPT exposure suggest that oxidative damage is a contributory mechanism for the DMPT toxicity and/or carcinogenic effects.

Figure 7.

Proposed N, N-dimethyl-p-toluidine nasal cavity toxicity pathways.

We gratefully acknowledge technical support from B. Mahler, E. Hou, R. Fannin, O. Lyght, and R. Wilson. The in-life portion of this study was conducted under NIEHS contract NO1-ES-75561 with Alion Science & Technology, Inc. We thank Drs. M. Cesta and D. Malarkey (NIEHS) for their excellent review of the article.

Authors contributed to conception or design (JD, BM, AB, DM, GF, JF, KS, YW). All authors (JD, BM, AB, DM, KG, GF, JF, KS, YW) contributed to the data acquisition, analysis, or interpretation; drafting and critically revising the manuscript and gave final approval and agreed to be accountable for all aspects of work in ensuring that questions relating to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

The statements, opinions, or conclusions contained therein do not necessarily represent the statements, opinions, or conclusions of NIEHS, NIH, or the U. S. government.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The intramural program of the National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, supported this work.

The online [appendices/data supplements/etc] are available at .

Anakk

Kalsotra

Shen

M. T.

Staudinger

J. L.

Davies

P. J.

Strobel

H. W.

(2003). Genomic characterization and regulation of CYP3a13: Role of xenobiotics and nuclear receptors. FASEB 17, 1736–38.

Andersen

M. E.

Clewell

H. J.

3rd Bermudez

Dodd

D. E.

Willson

G. A.

Campbell

J. L.

Thomas

R. S.

(2010). Formaldehyde: Integrating dosimetry, cytotoxicity, and genomics to understand dose-dependent transitions for an endogenous compound. Toxicol Sci 118, 716–31.

Baek

J. Y.

Han

S. H.

Sung

S. H.

Lee

H. E.

Kim

Y. M.

Noh

Y. H.

Bae

S. H.

Rhee

S. G.

Chang

T. S.

(2012). Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H2O2. J Biol Chem 287, 81–89.

Basu

Banerjee

Rojas

Martinez

S. R.

Roy

Jia

Lilly

M. B.

De Leon

Casiano

C. A.

(2011). Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4. The Prostate 71, 755–65.

Bensellam

Montgomery

M. K.

Luzuriaga

Chan

J. Y.

Laybutt

D. R.

(2015). Inhibitor of differentiation proteins protect against oxidative stress by regulating the antioxidant-mitochondrial response in mouse beta cells. Diabetologia 58, 758–70.

Bhutia

Y. D.

Babu

Ramachandran

Ganapathy

(2015). Amino Acid transporters in cancer and their relevance to “glutamine addiction”: Novel targets for the design of a new class of anticancer drugs. Cancer Res 75, 1782–88.

Boorman

G. A.

Morgan

K. T.

Uriah

L. C.

(1990). Nose, Larynx, and Trachea. In Pathology of the Fischer Rat—Reference and Atlas ( Boorman

G. A.

Eustis

S. L.

Elwell

M. R.

Montgomery

C. A.

Jr. MacKenzie

W. F.

, eds.), pp. 315–37. Academic Press, New York.

Brockschnieder

Sabanay

Riethmacher

Peles

(2006). Ermin, a myelinating oligodendrocyte-specific protein that regulates cell morphology. J Neurosci 26, 757–62.

Cao

Liu

Tang

Bao

Shen

Yuan

Zhao

(2008). Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two Bhuman cell lines. Biochim Biophy Acta 1780, 873–80.

10.

Cattaneo

McKay

(1990). Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature 347, 762–65.

11.

Dallaglio

Marconi

Truzzi

Lotti

Palazzo

Petrachi

Saltari

Coppini

Pincelli

(2013). E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro. Exp Dermat 22, 255–61.

12.

Das

S. K.

Sharma

N. K.

Hasstedt

S. J.

Mondal

A. K.

Langberg

K. A.

Elbein

S. C.

(2011). An integrative genomics approach identifies activation of thioredoxin/thioredoxin reductase-1-mediated oxidative stress defense pathway and inhibition of angiogenesis in obese nondiabetic human subjects. J Clin Endocrinol Metab 96, E1308–13.

13.

Dix

K. J.

Ghanbari

Hedtke-Weber

B. M.

(2007). Disposition of [14C]N, N-dimethyl-p-toluidine in F344 rats and B6C3F1 mice. J Toxicol Environ Health A 70, 789–98.

14.

Dunnick

J. K.

Brix

Sanders

J. M.

Travlos

G. S.

(2014). N, N-dimethyl-p-toluidine, a component in dental materials, causes hematologic toxic and carcinogenic responses in rodent model systems. Toxicol Pathol 42, 603–15.

15.

El-Gebali

Bentz

Hediger

M. A.

Anderle

(2013). Solute carriers (SLCs) in cancer. Mol Aspects Med 34, 719–34.

16.

Evelyn

K. A.

Malloy

H. T.

(1938). Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J Biol Chem 126, 655–62.

17.

Fang

L. Y.

Wong

T. Y.

Chiang

W. F.

Chen

Y. L.

(2010). Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J Oral Pathol 39, 342–48.

18.

Franco

Bortner

C. D.

Schmitz

Cidlowski

J. A.

(2014). Glutathione depletion regulates both extrinsic and intrinsic apoptotic signaling cascades independent from multidrug resistance protein 1. Apoptosis 19, 117–34.

19.

Guo

Chen

Z. M.

Qiu

G. B.

Zhong

Sun

K. L.

W. N.

(2011). MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis. PLoS One 6, e25648.

20.

Fujimoto

Nakanishi

Arata

Jetten

A. M.

(1997). Differential expression of human cornifin alpha and beta in squamous differentiating epithelial tissues and several skin lesions. J Invest Dermat 108, 200–04.

21.

Gautier

Cope

Bolstad

B. M.

Irizarry

R. A.

(2004). Affy—Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307–15.

22.

Hanahan

Weinberg

R. A.

(2011). Hallmarks of cancer: The next generation. Cell 144, 646–74.

23.

Hardisty

J. F.

Garman

R. H.

Harkema

J. R.

Lomax

L. G.

Morgan

K. T.

(1999). Histopathology of nasal olfactory mucosa from selected inhalation toxicity studies conducted with volatile chemicals. Toxicol Pathol 27, 618–27.

24.

Harkema

J. R.

Carey

S. A.

Wagner

J. G.

(2006). The nose revisited: A brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium. Toxicol Pathol 34, 252–69.

25.

Hasmim

Badoual

Vielh

Drusch

Marty

Laplanche

de Oliveira Diniz

Roussel

De Guillebon

Oudard

Hans

Tartour

Chouaib

(2013). Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells. BMC Cancer 13, 592.

26.

Hediger

M. A.

Clemencon

Burrier

R. E.

Bruford

E. A.

(2013). The ABCs of membrane transporters in health and disease (SLC series): Introduction. Mol Aspects Med 34, 95–107.

27.

Huang

Liu

Xie

Liu

Shao

Zhu

C. L.

(2014). Fragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway. Scientific World Journal 2014, 179698.

28.

Huang

Dai

Barbacioru

Sadee

(2005). Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res 65, 7446–54.

29.

International Agency for Research on Cancer. (2012). IARC Monograph on the evaluation of carcinogenic risks to humans. Chemical agents and related occupations . Accessed July 15, 2015. http://monographs.iarc.fr/ENG/Monographs/vol100F/index.php.

30.

Irizarry

R. A.

Hobbs

Collin

Beazer-Barclay

Y. D.

Antonellis

K. J.

Scherf

Speed

T. P.

(2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–64.

31.

Izawa

Pines

(2015). The mitotic checkpoint complex binds a second CDC20 to inhibit active APC/C. Nature 517, 631–34.

32.

Jarzab

Filipowska

Zebracka

Kowalska

Bozek

Rachowska

Gubala

Grzanka

Hadas

Jarzab

(2010). Locus 1q21 Gene expression changes in atopic dermatitis skin lesions: deregulation of small proline-rich region 1A. Int Arch Allergy Immunol 151, 28–37.

33.

Jensen

M. M.

Arvaniti

Mikkelsen

J. D.

Michalski

Pinborg

L. H.

Hartig

Thomsen

M. S.

(2015). Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer’s disease. Neurobiology of Aging 36, 1629–38.

34.

Jobling

Pundavela

Oliveira

S. M.

Roselli

Walker

M. M.

Hondermarck

(2015). Nerve-cancer cell cross-talk: A novel promoter of tumor progression. Cancer Res 75, 1777–81.

35.

Johnson

J. A.

Johnson

D. A.

Kraft

A. D.

Calkins

M. J.

Jakel

R. J.

Vargas

M. R.

Chen

P. C.

(2008). The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann N Y Acad Sci 1147, 61–69.

36.

Katsuoka

Motohashi

Ishii

Aburatani

Engel

J. D.

Yamamoto

(2005). Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol Cell Biol 25, 8044–51.

37.

Kim

N. C.

Ghanbari

Kracko

D. A.

Weber

W. M.

McDonald

J. D.

Dix

K. J.

(2007). Identification of urinary metabolites of orally administered N, N-dimethyl-p-toluidine in male F344 rats. J Toxicol Environ Health A 70, 781–88.

38.

Klaunig

J. E.

Wang

Zhou

(2011). Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol 254, 86–99.

39.

Knight

L. P.

Primiano

Groopman

J. D.

Kensler

T. W.

Sutter

T. R.

(1999). cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis 20, 1215–23.

40.

Kobayashi

Kuwata

Sugimoto

Igarashi

Osaki

Okada

Fujii

Bannai

Sato

(2012). Enhanced expression of cystine/glutamate transporter in the lung caused by the oxidative-stress-inducing agent paraquat. Free Radic Biol Med 53, 2197–203.

41.

Kuan

C. Y.

Roth

K. A.

Flavell

R. A.

Rakic

(2000). Mechanisms of programmed cell death in the developing brain. Trends Neurosci 23, 291–97.

42.

Kupershmidt

Q. J.

Grewal

Sundaresh

Halperin

Flynn

Shekar

Wang

Park

Cui

Wall

G. D.

Wisotzkey

Alag

Akhtari

Ronaghi

(2010). Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5, e13066.

43.

Liu

Wang

L. E.

Liu

Chen

W. V.

Amos

C. I.

Lee

J. E.

Iles

M. M.

Law

M. H.

Barrett

J. H.

Montgomery

G. W.

Taylor

J. C.

MacGregor

Cust

A. E.

Newton Bishop

J. A.

Hayward

N. K.

Bishop

D. T.

Mann

G. J.

Affleck

Wei

(2013). Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk. Carcinogenesi 34, 885–92.

44.

Gao

Fan

Zhang

Chen

Zhang

Song

Huang

Wang

Zheng

Shi

Zhang

(2013). Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma. PLoS One 8, e73436.

45.

Massrieh

Derjuga

Doualla-Bell

C. Y.

Sanborn

B. M.

Blank

(2006). Regulation of the MAFF transcription factor by proinflammatory cytokines in myometrial cells. Biol Reprod 74, 699–705.

46.

Merrick

B. A.

Auerbach

S. S.

Stockton

P. S.

Foley

J. F.

Malarkey

D. E.

Sills

R. C.

Irwin

R. D.

Tice

R. R.

(2012). Testing an aflatoxin B1 gene signature in rat archival tissues. Chem Res Toxicol 25, 1132–44.

47.

Merrick

B. A.

Phadke

D. P.

Auerbach

S. S.

Mav

Stiegelmeyer

S. M.

Shah

R. R.

Tice

R. R.

(2013). RNA-Seq profiling reveals novel hepatic gene expression pattern in aflatoxin B1 treated rats. PLoS One 8, e61768.

48.

National Toxicology Program. (2012). Toxicology and carcinogenesis studies of N,N-dimethyl-p-toluidine (CAS No. 99-97-8) in F344/N rats and B6C3F1/N mice (gavage studies). Natl Toxicol Program Tech Rep Ser 579, 1–211.

49.

National Toxicology Program. (2014). NTP long-term study reports and absracts. Accessed July 15, 2015. http://ntp.niehs.nih.gov/?objectid=084801F0-F43F-7B74-0BE549908B5E5C1C.

50.

S. B.

Selvarajan

Huang

Zhou

Feldman

A. L.

Law

Kwong

Y. L.

Shimizu

Kagami

Aozasa

Salto-Tellez

Chng

W. J.

(2011). Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling. J Pathol 223, 496–510.

51.

Nguyen

Nioi

Pickett

C. B.

(2009). The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284, 13291–95.

52.

Office of Environmental Health Hazard Assessment. (2014). Chemical listed effective MAY 2, 2014 as known to the State of California to cause cancer: N, N-Dimethyl-p-toluidine. Accessed July 15, 2015. http://oehha.ca.gov/Prop65/prop65_list/050214list.html.

53.

Pallais

J. C.

Mackool

B. T.

Pitman

M. B.

(2011). Case records of the Massachusetts General Hospital: Case 7-2011: A 52-year-old man with upper respiratory symptoms and low oxygen saturation levels. N Engl J Med 364, 957–66.

54.

Pandolfi

P. P.

Sonati

Rivi

Mason

Grosveld

Luzzatto

(1995). Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 14, 5209–15.

55.

Parsi

Soltani

B. M.

Hosseini

Tousi

S. E.

Mowla

S. J.

(2012). Experimental verification of a predicted intronic microRNA in human NGFR gene with a potential pro-apoptotic function. PLoS One 7, e35561.

56.

Pavlidis

Romanidou

Roggenbuck

Mytilinaiou

M. G.

Al-Sulttan

Liaskos

Smyk

D. S.

Koutsoumpas

A. L.

Rigopoulou

E. I.

Conrad

Forbes

Bogdanos

D. P.

(2012). Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn’s disease. Clin Develop Immunol 2012, 640835.

57.

Peddada

Harris

Zajd

Harvey

(2005). ORIOGEN: Order restricted inference for ordered gene expression data. Bioinformatics 21, 3933–34.

58.

Petrocca

Vecchione

Croce

C. M.

(2008). Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68, 8191–94.

59.

Presland

R. B.

Dale

B. A.

(2000). Epithelial structural proteins of the skin and oral cavity: Function in health and disease. Crit Rev Oral Biol Med 11, 383–408.

60.

Roig

M. B.

Roset

Ortet

Balsiger

N. A.

Anfosso

Cabellos

Garrido

Alameda

Brady

H. J.

Gil-Gomez

(2009). Identification of a novel cyclin required for the intrinsic apoptosis pathway in lymphoid cells. Cell Death Differ 16, 230–43.

61.

Sahasrabuddhe

N. A.

Huang

T. C.

Ahmad

Kim

M. S.

Yang

Ghosh

Leach

S. D.

Gowda

Somani

B. L.

Chaerkady

Pandey

(2014). Regulation of PPAR-alpha pathway by Dicer revealed through proteomic analysis. J Proteomics 108, 306–15.

62.

Shepelev

M. V.

Korobko

I. V.

(2013). The RHOV gene is overexpressed in human non-small cell lung cancer. Cancer Genet 206, 393–97.

63.

Singer

Judkins

Salomonis

Matlaf

Soteropoulos

McAllister

Soroceanu

(2015). Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Cell Death Dis 6, e1601.

64.

Subramanian

Tamayo

Mootha

V. K.

Mukherjee

Ebert

B. L.

Gillette

M. A.

Paulovich

Pomeroy

S. L.

Golub

T. R.

Lander

E. S.

Mesirov

J. P.

(2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceed Natl Acad Sci 102, 15545–50.

65.

Tesfaigzi

Th’ng

Hotchkiss

J. A.

Harkema

J. R.

Wright

P. S.

(1996). A small proline-rich protein, SPRR1, is upregulated early during tobacco smoke-induced squamous metaplasia in rat nasal epithelia. Am J Respir Cell Mol Biol 14, 478–86.

66.

Thameem

Yang

Permana

P. A.

Wolford

J. K.

Bogardus

Prochazka

(2003). Evaluation of the microsomal glutathione S-transferase 3 (MGST3) locus on 1q23 as a Type 2 diabetes susceptibility gene in Pima Indians. Human Gen 113, 353–58.

67.

U.S. Patent and Trademark Office. (2015). U.S. patent and trademark office Patent Database. Accessed July 15, 2015. http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=N%2CN-Dimethyl-p-toluidine&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PG01.

68.

Wang

Yoon

D. M.

Spicer

P. P.

Henslee

A. M.

Scott

D. W.

Wong

M. E.

Kasper

F. K.

Mikos

A. G.

(2013). Characterization of porous polymethylmethacrylate space maintainers for craniofacial reconstruction. J Biomed Mater Res B Appl Biomater 101, 813–25.

69.

Wang

Yuan

Dong

Yang

Lin

Gong

(2015). Humid heat exposure induced oxidative stress and apoptosis in cardiomyocytes through the angiotensin II signaling pathway. Heart Vessels 30, 396–405.

70.

Waters

C. E.

Saldivar

J. C.

Hosseini

S. A.

Huebner

(2014). The FHIT gene product: Tumor suppressor and genome “caretaker.” Cell Mol Life Sci: CMLS 71, 4577–87.

71.

Werner

Paclik

Fritz

Reinhold

Roggenbuck

Sturm

(2012). Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses. J Immunol 189, 2774–83.

72.

X. F.

Guo

C. Y.

Liu

Yang

W. J.

Xia

Y. J.

Y. C.

Wang

X. P.

(2009). Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J Carcinog 8, 13.

73.

Yang

Guo

Liu

Tian

(2014). Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications. Expert Rev Anticancer Ther 14, 31–37.

74.

Yong

Jianting

Liting

Xuansheng

Fei

Jiewen

(2014). Upregulation of sestrin-2 expression protects against endothelial toxicity of angiotensin II. Cell Biol Toxicol 30, 147–56.

75.

Zhong

Cherry

Bies

C. E.

Florence

M. A.

Gerges

N. Z.

(2009). Neurogranin enhances synaptic strength through its interaction with calmodulin. EMBO J 28, 3027–39.

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.35 MB

0.03 MB

0.05 MB

0.03 MB

0.05 MB

1.19 MB

Angiectasis

Transitional epithelium hyperplasia

Olfactory epithelium necrosis

Olfactory epithelium degeneration